Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1227 publications
O'nyong'nyong Virus Infections in Nigeria: A Case Series.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 20, 2025
Viral hemorrhagic fevers - therapeutic trial advances and challenges.
Journal: Expert review of anti-infective therapy
Published: November 17, 2025
Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate.
Journal: The New England journal of medicine
Published: November 05, 2025
Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccine.
Journal: The Journal of general virology
Published: October 06, 2025
Robust polyfunctional CD8+ and CD4+ T cell responses in HLA-A*0201/DR1 transgenic mice following vaccination with modified vaccinia virus Ankara-based vaccines delivering Lassa virus glycoprotein or nucleoprotein.
Journal: The Journal of general virology
Published: September 01, 2025
CD4+ and CD8+ T cells are not the main driver of Lassa fever pathogenesis in macaques.
Journal: JCI insight
Published: August 15, 2025
Serological Evidence of Lassa Virus Exposure in Non-Mastomys Small Mammals Within a Hyperendemic Region of North-Central Nigeria: A Pilot Study.
Journal: Viruses
Published: August 01, 2025
The significance of studying high-consequence pathogens in their natural reservoirs.
Journal: Advances in virus research
Published: July 23, 2025
Safety Toxicology Study of Reassortant Mopeia-Lassa Vaccine in Guinea Pigs.
Journal: Future pharmacology
Published: July 16, 2025
Clinical Outcomes of Severe Lassa Fever in West Africa: A Systematic Review and Meta-Analysis.
Journal: International journal of environmental research and public health
Published: July 06, 2025
Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults.
Journal: Frontiers in immunology
Published: July 02, 2025
One Health, Many Gaps: Rethinking Epidemic Intelligence in Resource-Limited Settings to Prepare for the Global Threat of Disease X.
Journal: Microorganisms
Published: June 20, 2025
Last Updated: 01/07/2026